Literature DB >> 20634678

Management of unruptured intracranial aneurysms and arteriovenous malformations.

Maggie L McNulty1, Vivien H Lee.   

Abstract

The natural history and optimal treatment for unruptured cerebral aneurysm and arteriovenous malformations (AVMs) remains unknown. The prevalence of intracranial aneurysms is estimated to be between 1% and 5%. The annual risk of rupture for small aneurysms in the anterior circulation is low. Factors that are associated with increased risk of rupture include location of the aneurysm in the posterior circulation and size of the aneurysm greater than 7 mm in diameter. Management options of unruptured intracranial aneurysms include conservative management, endovascular, or surgical treatment. AVMs are estimated to have a prevalence of 1.4% to 4.3%. The annual risk of rupture of AVMs that did not present with hemorrhage is low at approximately 0.9% per year. Factors that increase the risk of rupture include hemorrhagic presentation, deep AVM location, or deep venous drainage associated with the AVM. The treatment options for AVM available include conservative management, microsurgery, endovascular treatment, radiosurgery, or a combination of methods.

Entities:  

Mesh:

Year:  2011        PMID: 20634678     DOI: 10.1097/MJT.0b013e3181e4ddc6

Source DB:  PubMed          Journal:  Am J Ther        ISSN: 1075-2765            Impact factor:   2.688


  3 in total

Review 1.  Vascular disruption and blood-brain barrier dysfunction in intracerebral hemorrhage.

Authors:  Richard F Keep; Ningna Zhou; Jianming Xiang; Anuska V Andjelkovic; Ya Hua; Guohua Xi
Journal:  Fluids Barriers CNS       Date:  2014-08-10

2.  Functional MRI-guided microsurgery of intracranial arteriovenous malformations: study protocol for a randomised controlled trial.

Authors:  Bing Zhao; Yong Cao; Yuanli Zhao; Jun Wu; Shuo Wang
Journal:  BMJ Open       Date:  2014-10-23       Impact factor: 2.692

3.  Hybrid operation for arteriovenous malformations with associated multiple intracranial aneurysms and subarachnoid hemorrhage: Case report.

Authors:  Fei Xie; Lin Huang; Yongqiang Ye; Jianqiang Hao; Janwei Lv; Seidu A Richard
Journal:  Medicine (Baltimore)       Date:  2022-02-25       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.